![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 20, 2018 5:57:16 PM
-Regulatory requirements have been clarified for US and Europe.
-45 pre-clinical studies that have guided the optimization of SPORT.
-Enough cash on hand to get through 2nd quarter of 2019.
-Advincula likes what he sees.
-Advincula presenting his experiences with SPORT in Milan, Italy next week.
-McNally doing several more presentations this year.
The regulatory requirements being clarified was the best news imo. Other than that seemed like they were just trying to boost investor confidence...perhaps that means they are counting on the 3.20 warrants to get exercised once they are in the money.
There was a very good question about the need for an additional arm for retraction purposes...Advincula addressed the concern very satisfactorily with the mention of those $50 subcutaneous retractors that are being used even on DaVinci cases.
Did anyone get the name of the Canadian consultation company that McNally mentioned that Titan has been working with?
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM